Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Genome-Wide CRISPR Screening Identifies MAPK and Mtorc Pathways As Regulators of Sorafenib Resistance in Acute Myeloid Leukemia

Alisa Damnernsawad, PhD, Tamilla Nechiporuk, PhD, Daniel Bottomly, MS, Stephen E Kurtz, PhD, Christopher A. Eide, Shannon K. McWeeney, PhD, Jeffrey W. Tyner

Blood (2019) 134 (Supplement_1): 2557.

https://doi.org/10.1182/blood-2019-128877

Published: 2019

Journal Articles

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Siliang Chen, Zheyuan Qin, Stephen Liang, MD

Blood (2018) 132 (Supplement 1): 5903.

https://doi.org/10.1182/blood-2018-99-118481

Published: 2018

Journal Articles

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Viera Sandecka, MD PhD, Ludek Pour, MD, Zdenek Adam, Prof, MD CSc, Martin Stork, MD, Marta Krejci, Prof, MD PhD, Jana Michalcova, MD, Zdenek Kral, MD CSc, Sabina Sevcikova, PhD, Zdeněk Řehák, MD PhD, Renata Koukalova, MD

Blood (2018) 132 (Supplement 1): 1913.

https://doi.org/10.1182/blood-2018-99-111094

Published: 2018

Journal Articles

Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major

Alessia Pepe, MD, Antonella Meloni, PhD, Stella Santarone, Annalisa Natale, Mauro Di Ianni, MD PhD, Laura Pistoia, MD, Liana Cuccia, MD, Anna Spasiano, Roberto Lisi, Paolo Di Bartolomeo, MD

Blood (2017) 130 (Supplement 1): 3274.

https://doi.org/10.1182/blood.V130.Suppl_1.3274.3274

Published: 2017

Journal Articles

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

Blood (2016) 128 (22): 2775.

https://doi.org/10.1182/blood.V128.22.2775.2775

Published: 2016

Journal Articles

Secondary ALL May be Independent of Prior Cytotoxic Therapy

Chezi Ganzel, MD, Sean M. Devlin, PhD, Dan Douer, MD, Eytan M. Stein, Jacob M. Rowe, MD, Martin S. Tallman, MD

Blood (2014) 124 (21): 3648.

https://doi.org/10.1182/blood.V124.21.3648.3648

Published: 2014

Journal Articles

Occurrence of Neoplastic Diseases in a Large Cohort of Thalassemic Patients in Greece

Alexandra Kouraklis, MD, PhD, Antonia Chatziliami, MD, Antonis Kattamis, MD, PhD, Efthimia Vlachaki, MD, PhD, Evangelos Briasoulis, MD, PhD, Ioannis Lafiatis, MD, Polyxeni Lampropoulou, MD, Christina Fragodimitri, MD, Aggeliki Moira, MD, Argiris Symeonidis, MD, PhD

Blood (2012) 120 (21): 3264.

https://doi.org/10.1182/blood.V120.21.3264.3264

Published: 2012

Journal Articles

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 661.

https://doi.org/10.1182/blood.V120.21.661.661

Published: 2012

Journal Articles

The Expression of BAG3 Gene in Chronic Lymphocytic Leukemia and Its Clinical Significance

Huayuan Zhu, Peng Liu, Jianyong Li, MD, PhD

Blood (2011) 118 (21): 4605.

https://doi.org/10.1182/blood.V118.21.4605.4605

Published: 2011

Journal Articles

Proteomics as a Functional Tool in Evaluating Bortezomib Treatment and Drug Resistance Mechanism.

Melissa G Ooi, M.D., Paul Dowling, Ph.D, Paul Richardson, M.D., Constantine S. Mitsiades, M.D., Ph.D, Martin Clynes, Ph.D, Kenneth C. Anderson, Peter O'Gorman, M.D.

Blood (2009) 114 (22): 1805.

https://doi.org/10.1182/blood.V114.22.1805.1805

Published: 2009

Journal Articles

Analysis of Long-Term Outcome and the Risk of Second Malignancies in Hodgkin Lymphoma Survivors

Ida Cedrych, MD, Slawomir Blamek, MD, Andrzej Deptala, MD, PhD, Krzysztof Skladowski, MD, PhD

Blood (2008) 112 (11): 4953.

https://doi.org/10.1182/blood.V112.11.4953.4953

Published: 2008

Journal Articles

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.

Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Marco Sorio, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Atto Billio, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD, Sergio Cortelazzo, MD

Blood (2006) 108 (11): 2744.

https://doi.org/10.1182/blood.V108.11.2744.2744

Published: 2006

Journal Articles

High Risk Hairy Cell Leukemia (HCL) Treatment with Fludarabine: Report of Three Cases with Low Toxicity and Durable Responses.

Antonio A. Carrasco-Yalan, MD, Olga M. López-Odría, MD, Luis Riva-Gonzales, MD, Pilar Quiñones-Avila, MD, Fernando Cauvi-R, MD, Sergio A. Murillo-Vizcarra, MD, Jorge S. Valdés-Gómez, MD, Julia Huamaní-Zavala, PharmD, Jorge A. Castillo-Aguirre, MD, Brady E. Beltrán-Gárate, MD

Blood (2005) 106 (11): 4769.

https://doi.org/10.1182/blood.V106.11.4769.4769

Published: 2005

Journal Articles

Evaluation of the Ras/B-Raf/SHP-2 Axis in B Cell Malignancies.

Constantine S. Mitsiades, MD, PhD, Nicholas Mitsiades, MD, PhD, Galinos Fanourakis, BSc, Athina Goudopoulou, BSc, Ciaran J. McMullan, MSc, Gerasimos Voutsinas, PhD, Nikhil C. Munshi, MD, PhD, Kenneth C. Anderson, MD

Blood (2004) 104 (11): 4344.

https://doi.org/10.1182/blood.V104.11.4344.4344

Published: 2004

Journal Articles

Intensive Treatment of Children With Acute Lymphoblastic Leukemia According to ALL-BFM-86 Without Cranial Radiotherapy: Results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)

W.A. Kamps, J.P.M. Bökkerink, K. Hählen, J. Hermans, H. Riehm, H. Gadner, M. Schrappe, R. Slater, E. van den Berg-de Ruiter, L.A. Smets, G.A.M. de Vaan, R.S. Weening, J.F. van Weerden, E.R. van Wering, A. van der Does-van den Berg

Blood (1999) 94 (4): 1226–1236.

https://doi.org/10.1182/blood.V94.4.1226

Published: 1999

NARROW

Genome-Wide CRISPR Screening Identifies MAPK and Mtorc Pathways As Regulators of Sorafenib Resistance in Acute Myeloid Leukemia

A Twenty Years Epidemiology Study of 2 nd Hematological Malignancies Post to the Initial Tumor Treatment: Report from Southern China Single Cancer Group

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Secondary Solid Cancer Following Hematopoietic Cell Transplantation in Patients with Thalassemia Major

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

Secondary ALL May be Independent of Prior Cytotoxic Therapy

Occurrence of Neoplastic Diseases in a Large Cohort of Thalassemic Patients in Greece

Second Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

The Expression of BAG3 Gene in Chronic Lymphocytic Leukemia and Its Clinical Significance

Proteomics as a Functional Tool in Evaluating Bortezomib Treatment and Drug Resistance Mechanism.

Analysis of Long-Term Outcome and the Risk of Second Malignancies in Hodgkin Lymphoma Survivors

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.

High Risk Hairy Cell Leukemia (HCL) Treatment with Fludarabine: Report of Three Cases with Low Toxicity and Durable Responses.

Evaluation of the Ras/B-Raf/SHP-2 Axis in B Cell Malignancies.

Intensive Treatment of Children With Acute Lymphoblastic Leukemia According to ALL-BFM-86 Without Cranial Radiotherapy: Results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only